Advances in Precision Medicine (APM) is an international Open Access journal that brings together all aspects of the rapidly growing field of personalized and precision medicine. The journal publishes original research articles and review articles related to all areas of precision medicine, providing a high-quality academic platform for the dissemination of cutting-edge theoretical and applied research in the field.

Biomarkers are a key focus of APM's scope. In particular, papers on stratification biomarkers and companion diagnostics enabling personalized medicine are highly welcome. Other categories of biomarkers accepted for consideration include pharmacodynamic biomarkers demonstrating target engagement which are potentially useful for dose finding, safety biomarkers to exclude patients with high risk for side effects or to detect induction of adverse effects early, and disease biomarkers which can be used for diagnosis, as surrogate endpoints, or to determine early response to therapy.

The scope of the journal includes, but is not limited to: stratification biomarkers and companion diagnostics, pharmacodynamic biomarkers, safety biomarkers, disease biomarkers, genomic and molecular profiling, targeted therapies and individualized treatment strategies, clinical implementation of precision medicine, computational and bioinformatics approaches in precision medicine, and emerging topics at the intersection of precision medicine and related fields.

All accepted articles are published in Open Access format, allowing readers to freely read, download, and share the content, thereby promoting the widespread dissemination of research findings. The journal welcomes submissions from scholars and researchers worldwide.